
Keywords: آدنوکارسینوما دودکش; microRNA-331; Breast cancer; Breast benign tumors; Ductal adenocarcinoma; Lobular adenocarcinoma; Biomarker; ASCO; American Society of Clinical Oncologists; AUC; Area under the curve; CAP; College of American Pathologists; cDNA; Complementary DNA; DCIS; D